Let's talk about sex[uality]-related symptom burden in myeloproliferative neoplasms
A partir de données portant sur 1 971 patients atteints de syndromes myéloprolifératifs, cette étude prospective analyse la prévalence de difficultés et de symptômes de nature sexuelle et leur importance dans la qualité de vie des patients
Cancer, sous presse, 2016, éditorial
Résumé en anglais
Precis A thoughtful conversation about sexual symptom burden should occur as part of a comprehensive assessment of the overall well-being of patients with myeloproliferative neoplasms. In the article by Geyer et al in this issue of Cancer, the authors quantify the sexuality-related symptoms, along with quality of life, in patients with myeloproliferative neoplasms, and evaluate how they correspond to disease features and treatment.
